ClinicalTrials.gg
Status unknownNCT02298140(PCMT)Updated Aug 3, 2015

Providers' Compliance to Malaria Treatment

An interventional study of SMS reminders in Malaria, sponsored by Ifakara Health Institute. Status unknown at 1 site in Tanzania. Per ClinicalTrials.gov, last updated 2015-08-03.

Sponsored by Ifakara Health Institute · Not applicable, Interventional, and Health services research

How we know

The sponsor has not verified this record recently (last verified Jul 2015), so the status shown — last known as Recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
712
Allocation
Not applicable
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 79 studies in Malaria with a site in Tanzania — 3 open to participants now, 3 under way, none of them phase 3. Malaria · Tanzania.

Planned enrollment
35th of 72
712 · median 616
Started
2014
with 7 others
No phase
22 of 79
1 open now
Registered
47th of 79
by date
Lead sponsor
6 of 79
Ifakara Health Institute

Among the 79 studies in Malaria with a site in Tanzania, this one is the 35th largest by planned enrollment of the 72 interventional ones that give a count, is one of 8 that started in 2014, is one of 22 with no phase, and was the 47th registered.

Malaria

1,187 studies on the registry are indexed under Malaria; 80 are open to participants now.

Browse Malaria studies →

Open to participants now

3 of the 79 studies in Malaria with a site in Tanzania are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in Tanzania have not opened yet or have stopped. Only those recruiting at a site in Tanzania →

Who these studies take

Of the 51 Malaria studies recruiting now, 15 (29%) set no upper age limit and 33 (65%) stop at 75 or younger; 37 take children under 18; 31 take healthy volunteers.

This study: all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 79 studies in Malaria with a site in Tanzania, or all of them as a file.
02

Study summary

INDEPTH Network Effectiveness and Safety Studies in Africa (INESS) have demonstrated a substantial efficacy decay of Artemisinin based combination therapy (ACT) in Tanzania in 2012 (from efficacy of 98% to effectiveness of 18%). Hence system readiness for control and elimination strategies is severely compromised. Sub-optimal health workers' performance in treating malaria cases was a major contributor to the decay, effecting both treatment and patient adherence. If these quantified system failures remain unchecked it will pose major barrier in achieving malaria control and elimination goals. There is growing evidence that mobile phone text message reminders can improve health workers' compliance and patients' adherence to malaria treatment guidelines. Tanzania has recently harnessed all public sector health worker phones into Short Message System (SMS) platform. The investigators intend to exploit this opportunity in a randomized trial of messages to substantially reduce the decay documented by the INESS platform.

The null hypothesis: Sending automated text message reminders to health workers on malaria diagnosis and treatment recommendations, will not have any effects in the quality of malaria case management.

Read the detailed description

The baseline assessment of systems effectiveness performed by this team, have done a comprehensive quantitative documentation of efficacy decay for ACTs in real world settings; showing how community and provider's contribute to efficacy decay. The proposed text messages reminder intervention builds up from the recent findings of the Kenyan study which demonstrated an improvement in malaria case management by 24%. This level of improvement in malaria case management, if coupled with other systems interventions to improve timely access to ACT providers, should at least double systems effectiveness. This being the case, health systems in developing countries will be able to address these significant challenges hindering taking the diseases eradication agenda forward. Inappropriate care and untimely access to treatment has been identified as one of important elements for ACTs efficacy decay that in turn continues to pose a serious challenge to achieving malaria eradication.

Goal: The study aim to evaluate using cluster randomized control trial whether mobile phone text messages reminders can improve the quality of malaria case management.

Specific objectives:

  1. To develop an automated text messaging system to send reminders to mobile phones of health workers based on Tanzanian malaria treatment guidelines;
  2. To evaluate the impact of the intervention on providers' compliance to the National Guidelines for Malaria Diagnosis and Treatment (NGMDT);
  3. To evaluate the impact of the intervention on patients adherence to malaria treatment with ACT
  4. To evaluate the impact of the intervention on reducing baseline efficacy decay levels.
03

Conditions studied

  • Malaria

Browse trials for

Keywords

  • SMS reminders
  • Provider's compliance
  • malaria
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Dispensaries and health centers; public and private; operating in Rufiji district that provided outpatient services will be eligible for the study. In the intervention arm facility, all health workers who see and take care of patients at the outpatient department (OPD) will be registered to receive automated SMS as the intervention in this study.

During the evaluation phase, all patients attending the surveyed facilities for initial illness consultation will be eligible for inclusion in the study. Assessment of adherence will be performed to malaria patients (who tested positive) and received ACT for treatment.

Exclusion criteria

Exclusion Criteria:

Due to logistical difficulties, health facilities within the Delta region will be excluded in this study. As well, two hospitals in the district will be excluded in the study since they mostly receive referral patients. Also, hospitals have specialized clinic sections with highly trained staff and their nurses or clinicians may be rotating in different departments, hence there may not be health provider's whose primary duties are on OPD patients alone. In addition, health workers in eligible facilities who do not own a mobile phone will be excluded to receive "SMS" reminders.

During evaluation, all severe cases and hospitalized patients will not be included in the surveys. Assessment of adherence study will exclude non residents of the study area.

-

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
712 participants (estimated)

Study arms

  • Experimental
    SMS reminders

    This arm will receive automated mobile phone text message reminders for health workers in outpatient departments of public and private health facilities on issues related to care of malaria patients and suspected patients.

    Other: SMS reminders

Interventions

  • OtherSMS reminders

    Text-message reminders about malaria case management will be prepared and distributed to all health workers seeing outpatients in the selected health facilities through their personal mobile phones and facility phones. These messages will reflect ACT recommendations from Tanzania's national guidelines for the diagnosis and treatment of malaria and training manuals. The intervention will run for three months, two text message a day will be send to all identified health workers during regular working hours (i.e. between 8 am to 3 pm), three times a week. To avoid health worker's fatigue of receiving these messages, the messages will also contain some non-malaria humorous, inspirational, motivational and educative contents.

    Also known as: Post training reinforcement

06

What researchers measure

Primary outcomes

  1. Provider Compliance

    Proportion of patients presenting to health provider for initial illness consultation with fever (documented fever or history of fever within 48 hours); who are tested for malaria and prescribed ACT for test positive results or not prescribed any antimalarial for test negative results.

    Time frame: 10 months

Secondary outcomes

  1. Number of fever patients who received diagnostic test

    1) Proportion of fever patients receiving a diagnostic test to rule out/in malaria as per national guidelines.

    Time frame: 10 months

  2. Number of confirmed malaria patients treated with recommended antimalaria

    Proportion of malaria patients (fever with a positive test routine and gold standard) treated according to malaria treatment guidelines.

    Time frame: 10months

  3. Number of malaria patients who received correct dose of ACT

    Proportion of patients who receive a correct dose of ACT based on age and/or body weight for malaria treatment

    Time frame: 10 months

  4. Number of patients with a negative malaria test who did not receive antimalaria

    Proportion of negative tested patients who did not receive antimalarials

    Time frame: 10 months

  5. Number of afebrile patients who are tested for malaria

    Proportion of non-febrile (no fever or no history of fever within 48 hours) patients who are tested for malaria

    Time frame: 10 months

  6. Number of patients who received counselling messages

    Proportion of patients who received recommended counseling messages

    Time frame: 10 months

  7. Number of patients who completed antimalaria doses as instructed

    Proportion of complete and incomplete adherent patients, as prescribed by health worker.

    Time frame: 10 months

07

Study locations

1 of 1 sites recruiting
  • Ifakara Health Institute
    Rufiji, Pwani, Tanzania
    Recruiting
    • Neema Thomas, Nursing · Contacttneema80@yahoo.com · +255787139961
    • Asteria Massawe, Nursing · Contact+255754869939
    • Irene M Masanja, PhD · Principal investigator
    • Rashid A Khatib, PhD · Sub investigator
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Nov 2014, a primary completion of Dec 2015 and a completion of Dec 2015. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 1, 2014
First posted
Nov 21, 2014
Start
Nov 2014
Primary completionEst.
Dec 2015
CompletionEst.
Dec 2015
Last update
Aug 3, 2015
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 3, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02298140
Lead sponsor
Ifakara Health Institute
Collaborators
Swiss Tropical & Public Health Institute, KEMRI-Wellcome Trust Collaborative Research Program
Responsible party
Sponsor
First posted
Nov 21, 2014
Start date
Nov 2014
Primary completion
Dec 2015 (estimated)
Completion
Dec 2015 (estimated)
Last update
Aug 3, 2015

Study contacts

Irene M Masanja, PhD
Contact
imasanja@ihi.or.tz
+255786371240
Rashid A Khatib, PhD
Contact
rkhatib@ihi.or.tz
+255787926350
Don de Savigny, PhD
principal investigator · Swiss Tropical & Public Health

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion